Apotheek Callens SRL

Apotheek Callens reported total assets of 928,180 € at the end of the 2025 financial year (annual accounts filed with the NBB on 03 Jul 2026).

Company number (CBE) 0479.110.813 · VAT BE0479110813
9000 Ghent
active in Retail sale of pharmaceutical products (NACE 47730)
operating since 20 Dec 2002 (≈ 24 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Apotheek Callens shows with a free account.

See the score
Profile
SRL since 2002
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result13,752 €
Equity285,640 €
Cash50,030 €
EBITDA65,441 €
Total assets928,180 €
The line marks its sector median: 44.2% (2068 companies).

Change 2022 → 2025: Equity +14 % Total assets +58 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Apotheek Callens's annual accounts

20252024202320222021
Net result13,752 €
Equity285,640 €
Cash50,030 €
EBITDA65,441 €
Total assets928,180 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 03 Jul 2026
  • Year ended 31 Dec 2024filed on 09 Sep 2025
  • Year ended 31 Dec 2023filed on 30 Sep 2024
  • Year ended 31 Dec 2022filed on 27 Sep 2023
  • Year ended 31 Dec 2021filed on 14 Sep 2022

Apotheek Callens's financial analysis

Management and control of Apotheek Callens

1 active director(s) in the register.

Apotheek Callens's shareholders and holdings →

Apotheek Callens's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0479.110.813
VAT number
BE0479110813
Peppol
Registered · 0208:0479110813 · as of 10 Nov 2026
Legal form
SRL
Incorporated
20 Dec 2002
Registered office
9000 Ghent
Latest accounts
2025 · filed on 03 Jul 2026
Activity
Retail sale of pharmaceutical products (NACE 47730)

Apotheek Callens (SRL) has been based in Ghent since 2002, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 13,752 € and equity of 285,640 €; its revenue is not published. Its solvency stands at 30.8%, below the median of its sector (44.2%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Apotheek Callens

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Apotheek Callens

What is the revenue of Apotheek Callens?

Apotheek Callens files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Apotheek Callens?

In Belgium, the VAT number is the company number prefixed with BE: BE0479110813 for Apotheek Callens, if the company is VAT-registered. Its company number (CBE) is 0479.110.813.

Where is the registered office of Apotheek Callens?

According to the CBE register, the registered office of Apotheek Callens is in 9000 Ghent.

What is the equity of Apotheek Callens?

At the close of the 2025 financial year, the equity of Apotheek Callens amounts to 285,640 €, a solvency of 30.8% of total assets.

Who manages Apotheek Callens?

The register lists 1 active mandates at Apotheek Callens. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Apotheek Callens

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 11 Jul 2026

No credit card, no commitment.

What each plan unlocks →